6505--Radiopharmaceutical PLUVICTO 36C24826Q0189
Summary
AI-generated · Mar 09, 2026Sole-source justification for procuring PLUVICTO radiopharmaceutical from NOVARTIS PHARMACEUTICALS CORPORATION; the attached justification PDF explains the rationale for selecting this brand-name product rather than pursuing a competitive procurement.
An award in the amount of $4,732,607.88 was issued to NOVARTIS PHARMACEUTICALS CORPORATION.
See attached Justification PDF.
From Justification posted on Mar 03, 2026Notice history
1-
Justification LATEST Posted Mar 03, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | NG61ZA8TADW3 | N/A | EAST HANOVER |
Contacts
Contract Specialist
Phone